Insider · CIK 0001413822

Gianakakos Anastasios

CIK 0001413822 Name as filed on the most recent filing

Filed as Gianakakos Anastasios (97)

311 transaction lines · from 97 filings · filed 2008-05-19 to 2020-07-07 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

311 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2016-04-29 P, Open-market purchase MyoKardia IncMYOK 19,372, acquired Open Form 4 filing 0000899243-16-019447
2015-11-03 P, Open-market purchase MyoKardia IncMYOK 13,500, acquired Open Form 4 filing 0000899243-15-007674
2013-02-28 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 500,000, disposed Open Form 4 filing 0001181431-13-014206
2013-01-23 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 742,800, disposed Open Form 4 filing 0001181431-13-004933
2012-11-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 90,203, disposed Open Form 4 filing 0001181431-12-056736
2012-04-02 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 35,947, disposed Open Form 4 filing 0001181431-12-022453
2012-03-09 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 175,000, disposed Open Form 4 filing 0001181431-12-016913
2012-02-21 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 2 lines 40,017, disposed Open Form 4 filing 0001181431-12-010813
2012-02-06 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 150,000, disposed Open Form 4 filing 0001181431-12-006613
2012-01-19 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 62,078, disposed Open Form 4 filing 0001181431-12-003340
2011-12-12 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 2 lines 130,821, disposed Open Form 4 filing 0001181431-11-060452
2011-08-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 22,884, disposed Open Form 4 filing 0001181431-11-043665
2011-07-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 23,939, disposed Open Form 4 filing 0001181431-11-039616
2011-06-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 25,454, disposed Open Form 4 filing 0001181431-11-034597
2011-05-09 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 85,000, disposed Open Form 4 filing 0001181431-11-028498
2011-05-02 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 23,179, disposed Open Form 4 filing 0001181431-11-026743
2011-04-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 21,062, disposed Open Form 4 filing 0001181431-11-021830
2011-03-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 23,786, disposed Open Form 4 filing 0001181431-11-014650
2011-02-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 38,677, disposed Open Form 4 filing 0001181431-11-007002
2011-01-03 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 41,972, disposed Open Form 4 filing 0001181431-11-001150
2010-12-15 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 37,052, disposed Open Form 4 filing 0001181431-10-062533
2010-09-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 36,433, disposed Open Form 4 filing 0001181431-10-045637
2010-08-02 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 43,842, disposed Open Form 4 filing 0001181431-10-039657
2010-07-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 40,532, disposed Open Form 4 filing 0001181431-10-036047
2010-06-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 46,752, disposed Open Form 4 filing 0001181431-10-031077
2010-05-03 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 59,484, disposed Open Form 4 filing 0001181431-10-024531
2010-04-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 51,733, disposed Open Form 4 filing 0001181431-10-020346
2010-03-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 45,768, disposed Open Form 4 filing 0001181431-10-013627
2010-02-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 123,364, disposed Open Form 4 filing 0001181431-10-006429
2010-01-15 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 74,750, disposed Open Form 4 filing 0001181431-10-003531
2010-01-04 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 44,626, disposed Open Form 4 filing 0001181431-10-001630
2009-12-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 40,974, disposed Open Form 4 filing 0001181431-09-054478
2009-11-02 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 36,268, disposed Open Form 4 filing 0001181431-09-049904
2009-10-01 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 45,880, disposed Open Form 4 filing 0001181431-09-046827
2009-09-08 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 45,127, disposed Open Form 4 filing 0001181431-09-043288
2009-07-10 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 254,000, disposed Open Form 4 filing 0001181431-09-035272
2009-02-04 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 6 lines 180,037, disposed Open Form 4 filing 0001181431-09-006703
2008-07-07 S, Open-market sale MAP Pharmaceuticals, Inc.MAPP 6 lines 6,020, disposed Open Form 4 filing 0001181431-08-042501

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4
  • Open-market sale 307
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. GIANAKAKOS ANASTASIOS, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001413822

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.